Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hoth Therapeutics Inc 1177 Avenue of the Americas 5th Floor Suite 5066 New York NY 10036 USA

https://hoththerapeutics.com Employees: 3 P: 646-756-2997

Sector:

Medical

Description:

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 15,824
Enterprise Value, $K 8,784
Shares Outstanding, K 15,514
Float, K 14,440
% Float 93.08%
Short Interest, K 321
Short Float 2.07%
Days to Cover 1.00
Short Volume Ratio 0.62
% of Insider Shareholders 6.92%
% of Institutional Shareholders 7.08%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -8,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,110 K
EBIT, $ -12,140 K
EBITDA, $ -12,140 K

Growth:

1-Year Return -4.67%
3-Year Return -64.34%
5-Year Return -98.39%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 93.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/12/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Qtr -76.47%
EPS Growth vs. Prev Year 3.23%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/26/22

HOTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -133.69%
Return-on-Assets % -123.43%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.80
Book Value/Share 0.54
Interest Coverage -0.65
60-Month Beta 0.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar